Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

25.81
-0.8700-3.26%
Post-market: 25.810.00000.00%19:30 EDT
Volume:509.36K
Turnover:13.36M
Market Cap:1.10B
PE:15.30
High:26.79
Open:26.73
Low:25.77
Close:26.68
52wk High:29.52
52wk Low:16.65
Shares:42.54M
Float Shares:30.52M
Volume Ratio:0.90
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.69
EPS(LYR):2.03
ROE:10.30%
ROA:5.11%
PB:1.43
PE(LYR):12.71

Loading ...

Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 30, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]